Activated donor immune cells may prevent severe complication after allogeneic stem cell transplantation
Researchers have successfully conducted the first clinical trial using activated regulatory T cells (ATregs, Actileucel)—derived from white blood cells of healthy blood donors. This novel cell therapy aims to prevent graft-versus-host ...
49 minutes ago
0
0









